APA (7th ed.) Citation

Lu, J., Qiu, H., Wang, Y., Zhou, X., Dai, H., Lu, X., . . . Lei, Y. (2024). Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: A phase 2 trial. Journal of Hematology & Oncology, 17(1), 1. https://doi.org/10.1186/s13045-024-01597-8

Chicago Style (17th ed.) Citation

Lu, Jing, et al. "Reduced-dose Chemotherapy and Blinatumomab as Induction Treatment for Newly Diagnosed Ph-negative B-cell Precursor Acute Lymphoblastic Leukemia: A Phase 2 Trial." Journal of Hematology & Oncology 17, no. 1 (2024): 1. https://doi.org/10.1186/s13045-024-01597-8.

MLA (9th ed.) Citation

Lu, Jing, et al. "Reduced-dose Chemotherapy and Blinatumomab as Induction Treatment for Newly Diagnosed Ph-negative B-cell Precursor Acute Lymphoblastic Leukemia: A Phase 2 Trial." Journal of Hematology & Oncology, vol. 17, no. 1, 2024, p. 1, https://doi.org/10.1186/s13045-024-01597-8.